Attached files
| file | filename |
|---|---|
| 10-Q/A - 10-Q/A - Karyopharm Therapeutics Inc. | a14-24505_110qa.htm |
| EX-31.2 - EX-31.2 - Karyopharm Therapeutics Inc. | a14-24505_1ex31d2.htm |
Exhibit 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULE 13a-14(a)/15d-14(a) PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED
I, Michael Kauffman, M.D., Ph.D., certify that:
1. I have reviewed this Quarterly Report on Form 10-Q/A (Amendment No. 1) of Karyopharm Therapeutics Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
|
|
/s/ Michael Kauffman, M.D., Ph.D. |
|
|
Michael Kauffman, M.D., Ph.D. |
|
|
Chief Executive Officer |
|
|
(Principal executive officer) |
Date: November 14, 2014